Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Results Conference Call May 9, 2024 4:30 PM ET Company Participants Christopher James - Vice President of Investor Relations Joe Ciaffoni - Chief Executive Officer Colleen Tupper - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Mike Heffernan - Chairman Conference Call Participants David Amsellem - Piper Sandler Les Sulewski - Truist Securities Oren Livnat - H.C. Wainwright Operator Greetings. And welcome to the Collegium Pharmaceutical F ...